Article
Cancer pharmacogenomics, challenges in implementation, and patient-focused perspectives
1 Jul 2016
Abstract excerpt
Cancer pharmacogenomics is an evolving landscape and has the potential to significantly impact cancer care and precision medicine. Harnessing and understanding the genetic code of both the patient (germline) and the tumor (somatic) provides the opportunity for personalized dose and therapy selection for cancer patients. While germline DNA is useful in understanding the pharmacokinetic and pharmacodynamic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
